Granted Patent B2

US 12,496,413 · App. 16/970,846 · Granted Dec 16, 2025

Inventors: Gerard Zuber (Boulens, CH); Christopher Grant (Neuchâtel, CH); Daniele Sanna (Marin-Epagnier, CH); Gianluca Sechi (Colombier, CH); Judith Waller (Ostersund, SE); Niki Meloncelli (Castel Maggiore, IT)

Assignee: Philip Morris Products S.A.

A61M15/0005A24F42/20A24F42/60A61M15/0008A61M15/002A61M15/0021A61M15/0028A61M15/003A61M15/0033A61M15/0035A61M15/0041A61M15/06A61M2202/064A61M2206/16

Abstract

Claims (33)

1 . A dry powder inhaler, comprising:

an inhaler body extending from a mouthpiece end to a distal end, the inhaler body comprising a mouthpiece portion removably coupled to a distal end portion, the mouthpiece portion extending between the mouthpiece end and a first mating end, the distal end portion extending between a second mating end and the distal end,

the mouthpiece portion consisting of:

a capsule cavity defined within the first mating end;

a mouthpiece air channel extending from the mouthpiece end to the capsule cavity;

the distal end portion comprising:

an airflow element disposed within the distal end portion and extending a longitudinal length along a longitudinal axis to the capsule cavity, the airflow element comprises:

an airflow channel extending the longitudinal length of the airflow element and being non-parallel with the longitudinal axis, the airflow channel directs inlet air into the capsule cavity, and

a resealable membrane configured to reseal when a piercing element is withdrawn from the resealable membrane wherein the distal end portion is removable from the mouthpiece portion to access the capsule cavity.

2 . The dry powder inhaler according to claim 1 , wherein the airflow element comprises a second airflow channel extending the longitudinal length of the airflow element and being non-parallel with the longitudinal axis, wherein the airflow channel and the second airflow channel produce swirling air flow to induce rotation of a capsule contained within the capsule cavity.

3 . The dry powder inhaler according to claim 1 , wherein the airflow element has an airflow longitudinal length defined between a first lateral face and an opposing second lateral face, the airflow channel extends between the first lateral face and the second lateral face.

4 . The dry powder inhaler according to claim 3 , wherein the resealable membrane forms a portion of the first lateral face or second lateral face.

5 . The dry powder inhaler according to claim 3 , wherein the first lateral face defines an upstream boundary of the capsule cavity.

6 . The dry powder inhaler according to claim 1 , wherein the airflow channel defines a curved or arcuate or helical path along the longitudinal length of the airflow element.

7 . The dry powder inhaler according to claim 1 , wherein the airflow channel is curved and rotates around a circumference of the airflow element as a function of a location along the longitudinal length of the airflow element.

8 . The dry powder inhaler according to claim 1 , wherein the airflow channel comprises at least two opposing helical air channels that are symmetrical and each air channel extends along the longitudinal length of the airflow element.

9 . The dry powder inhaler according to claim 1 , wherein the airflow element comprises a linear piercing channel extending the longitudinal length of the airflow element, and the resealable membrane occludes the linear piercing channel.

10 . The dry powder inhaler according to claim 1 , wherein the piercing element is coupled to the distal end portion and adjacent to the distal end, the piercing element being configured to move between a relaxed position and a piercing position, the piercing element extending through the resealable membrane and into the capsule cavity in the piercing position, the piercing element being spaced apart from the resealable membrane in the relaxed position.

11 . The dry powder inhaler according to claim 1 , further comprising a receptacle disposed within the capsule cavity, the receptacle being a replaceable article of the dry powder inhaler, the receptacle is configured to contain a capsule.

12 . A dry powder inhaler system comprising:

the dry powder inhaler according to claim 1 ; and

a capsule disposed within the capsule cavity of the dry powder inhaler.

13 . The dry powder inhaler system according to claim 12 , wherein the capsule contains solid particles comprising nicotine.

14 . A method of delivering pharmaceutically active particles to the user, the method comprising:

providing the dry powder inhaler according to claim 1 ;

providing a capsule containing pharmaceutically active particles; and

delivering pharmaceutically active particles to a user using the dry powder inhaler and the capsule.

15 . The method according to claim 14 , wherein, the pharmaceutically active particles comprise nicotine.

16 . The dry powder inhaler according to claim 2 , wherein the longitudinal length of the airflow element is defined between a first lateral face and an opposing second lateral face, the airflow channel extends between the first lateral face and the second lateral face.

17 . The dry powder inhaler according to claim 4 , wherein the first lateral face defines an upstream boundary of the capsule cavity.

18 . The dry powder inhaler according to claim 3 , wherein the airflow channel defines a curved or arcuate or helical path along the longitudinal length of the airflow element.

19 . The dry powder inhaler according to claim 3 , wherein the airflow channel is curved and rotates around a circumference of the airflow element as a function of a location along the longitudinal length of the airflow element.

20 . The dry powder inhaler according to claim 3 , wherein the airflow element comprises a linear piercing channel extending the longitudinal length of the airflow element, and the resealable membrane occludes the linear piercing channel.

Assignments (1)

Priority Claims (1)

Continuity (1)

References Cited (30)